Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4561 AL 4575

Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies

Rygiel K.

Indian J Pharmacol. 2016 Nov-Dec;48(6):629-636. doi: 10.4103/0253-7613.194867.

Efficacy of Vitamin B Supplementation on Cognition in Elderly Patients With Cognitive-Related Diseases

Zhang DM, Ye JX, Mu JS, Cui XP.

J Geriatr Psychiatry Neurol. 2017 Jan;30(1):50-59. doi: 10.1177/0891988716673466. Epub 2016 Oct 17.

Amyloid-beta immunotherapy: the hope for Alzheimer disease?

Barrera-Ocampo A, Lopera F.

Colomb Med (Cali). 2016 Dec 30;47(4):203-212.

The Human Alzheimer Disease Project: Answering the Call

DeKosky ST, Growdon JH.

JAMA Neurol. 2016 Apr;73(4):373-4. doi: 10.1001/jamaneurol.2015.4512.

Influenza infections and risk of Alzheimer's disease

Imfeld P, Toovey S, Jick SS, Meier CR.

Brain Behav Immun. 2016 Oct;57:187-192. doi: 10.1016/j.bbi.2016.03.014. Epub 2016 Mar 19.

[Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease]

Petit AE, Mangeard H, Chazard E, Puisieux F.

Encephale. 2017 Feb;43(1):21-26. doi: 10.1016/j.encep.2015.03.006. Epub 2016 Mar 30.

Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries

Thorpe CT, Fowler NR, Harrigan K, Zhao X, Kang Y, Hanlon JT, Gellad WF, Schleiden LJ, Thorpe JM.

J Am Geriatr Soc. 2016 Sep;64(9):1806-14. doi: 10.1111/jgs.14403. Epub 2016 Aug 22.

Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease

Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Lavikainen P, Hartikainen S, Taipale H.

Ann Med. 2017 May;49(3):230-239. doi: 10.1080/07853890.2016.1254349. Epub 2016 Nov 29.

Alzheimer's disease, apolipoprotein E and hormone replacement therapy

Depypere H, Vierin A, Weyers S, Sieben A.

Maturitas. 2016 Dec;94:98-105. doi: 10.1016/j.maturitas.2016.09.009. Epub 2016 Sep 29.

Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation

Snyder HM, Ahles T, Calderwood S, Carrillo MC, Chen H, Chang CH, Craft S, De Jager P, Driver JA, Fillit H, Knopman D, Lotze M, Tierney MC, Petanceska S, Saykin A, Seshadri S, Shineman D, Ganguli M.

Alzheimers Dement. 2017 Mar;13(3):267-273. doi: 10.1016/j.jalz.2016.11.002. Epub 2016 Dec 18.

Characteristics of Tau and Its Ligands in PET Imaging

Harada R, Okamura N, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y.

Biomolecules. 2016 Jan 6;6(1):7. doi: 10.3390/biom6010007.

Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease

Ibarria M, Alegret M, Valero S, Morera A, Guitart M, Cañabate P, Moreno M, Lara S, Diego S, Hernández J, Tantinyá N, Vera M, Hernández I, Becker JT, Ruíz A, Boada M, Tárraga L.

J Alzheimers Dis. 2016;50(2):559-66. doi: 10.3233/JAD-150455.

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study

Ohnuma T, Toda A, Kimoto A, Takebayashi Y, Higashiyama R, Tagata Y, Ito M, Ota T, Shibata N, Arai H.

Clin Interv Aging. 2016 Jan 8;11:29-36. doi: 10.2147/CIA.S95362. eCollection 2016.

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease

Cummings JL, Zhong K, Kinney JW, Heaney C, Moll-Tudla J, Joshi A, Pontecorvo M, Devous M, Tang A, Bena J.

Alzheimers Res Ther. 2016 Jan 29;8:4. doi: 10.1186/s13195-016-0173-2.

Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients

Lee YM, Park JM, Lee BD, Moon E, Jeong HJ, Chung YI, Kim JH, Kim HJ, Mun CW, Kim TH, Kim YH.

J Clin Psychiatry. 2016 Jan;77(1):e8-13. doi: 10.4088/JCP.14m09740.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias